These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12197441)

  • 1. Detection of drug abuse by health professionals.
    Meeker JE; Mount AM; Ross W
    Occup Health Saf; 2002 Aug; 71(8):46-50. PubMed ID: 12197441
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of drug abuse by health professionals.
    Meeker JE; Mount AM; Ross W
    J Healthc Prot Manage; 2003; 19(1):73-81. PubMed ID: 12629790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tale of two drug testing technologies: GC-MS and LC-MS/MS.
    Mikel C; Pesce A; West C
    Pain Physician; 2010; 13(1):91-2. PubMed ID: 20119467
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of Xipamide metabolite in human urine by high-performance liquid chromatography/diode-array detection, high-performance liquid chromatography/electrospray ionization mass spectrometry and gas chromatography/mass spectrometry.
    Kim Y; Han K; Paeng KJ
    Rapid Commun Mass Spectrom; 2004; 18(20):2505-12. PubMed ID: 15384135
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid screening of drugs of abuse and their metabolites by gas chromatography/mass spectrometry: application to urinalysis.
    Strano-Rossi S; Molaioni F; Rossi F; Botrè F
    Rapid Commun Mass Spectrom; 2005; 19(11):1529-35. PubMed ID: 15880665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confronting drug abuse on the job.
    Brice J
    Healthc Forum J; 1990; 33(1):25-9. PubMed ID: 10104832
    [No Abstract]   [Full Text] [Related]  

  • 7. Just say no. Strict policies can help supervisors keep on-the-job drug abuse in check.
    Foltz-Gray D
    Contemp Longterm Care; 1996 Jun; 19(6):56-8, 60. PubMed ID: 10172677
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxy-amphetamine (DOI) in rat urine using gas chromatography-mass spectrometry.
    Ewald AH; Fritschi G; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):170-4. PubMed ID: 17632045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid in hair using gas chromatography/tandem mass spectrometry in negative ion chemical ionization mode.
    Kim JY; In MK
    Rapid Commun Mass Spectrom; 2007; 21(7):1339-42. PubMed ID: 17340556
    [No Abstract]   [Full Text] [Related]  

  • 10. [False positive screening for drugs of abuse].
    Watine J
    Ann Biol Clin (Paris); 2003; 61(3):367-8. PubMed ID: 12825552
    [No Abstract]   [Full Text] [Related]  

  • 11. Hair testing for delta9-THC-COOH by gas chromatography/tandem mass spectrometry in negative chemical ionization mode.
    Marsili R; Martello S; Felli M; Fiorina S; Chiarotti M
    Rapid Commun Mass Spectrom; 2005; 19(11):1566-8. PubMed ID: 15880614
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT; Taylor BG
    Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine drug screens.
    Cockrell K
    Indiana Med; 1991 Jun; 84(6):416-7. PubMed ID: 1918913
    [No Abstract]   [Full Text] [Related]  

  • 14. Implementing a mandatory drug screening program: pros and cons for the dialysis unit.
    Bednar B; Peacock E
    Nephrol News Issues; 1993 Jan; 7(1):14-5. PubMed ID: 8479549
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug & alcohol testing. Screening for safety.
    Current WF
    Occup Health Saf; 2001 Aug; 70(8):24, 26. PubMed ID: 11523281
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of opiates in biological samples through the analysis of heptafluorobutyric derivatives by gas chromatography/negative ion chemical ionization mass spectrometry.
    Acampora A; Della Casa E; Martone G; Miraglia N
    J Mass Spectrom; 2003 Sep; 38(9):1007-11. PubMed ID: 14505329
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of GC-MS and EIA results for the analysis of methadone in oral fluid.
    Cooper G; Wilson L; Reid C; Baldwin D; Hand C; Spiehler V
    J Forensic Sci; 2005 Jul; 50(4):928-32. PubMed ID: 16078500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. “AN ANESTHESIOLOGIST, A BRAIN SURGEON, AND A NURSE WALK INTO A BAR . . .” : A CALL FOR CHANGE IN HOW AMERICA HANDLES HEALTH CARE WORKER SUBSTANCE ABUSE.
    Halat A
    Seton Hall Law Rev; 2016; 46(3):939-90. PubMed ID: 27066612
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism of androsta-1,4,6-triene-3,17-dione and detection by gas chromatography/mass spectrometry in doping control.
    Parr MK; Fusshöller G; Schlörer N; Opfermann G; Piper T; Rodchenkov G; Schänzer W
    Rapid Commun Mass Spectrom; 2009 Jan; 23(2):207-18. PubMed ID: 19089863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug & alcohol testing. Oral fluid testing update.
    Andrie M
    Occup Health Saf; 2001 Aug; 70(8):32-4. PubMed ID: 11523283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.